The Regulatory Roles of Long Noncoding RNAs in Acute Myeloid Leukemia

by Michelle Ng, Dirk Heckl, Jan-Henning Klusmann
Published 2019-07-01

Molecular Approaches to Treating Pediatric Leukemias

by Michaela Kuhlen, Jan-Henning Klusmann, Jessica I. Hoell
Published 2019-09-01

Long noncoding RNAs as regulators of pediatric acute myeloid leukemia

by Sina Neyazi, Michelle Ng, Dirk Heckl, Jan-Henning Klusmann
Published 2022-05-01

Molecular Mechanisms of the Genetic Predisposition to Acute Megakaryoblastic Leukemia in Infants With Down Syndrome

by Juliane Grimm, Juliane Grimm, Dirk Heckl, Jan-Henning Klusmann
Published 2021-03-01

PB1788: A SCREENING OF DONATED CHEMICAL PROBES TO IDENTIFY NOVEL THERAPEUTIC OPTIONS FOR ACUTE MYELOID LEUKEMIA (AML) IN CHILDHOOD

by Stephanie Laszig, Raj Bhayadia, Jan-Henning Klusmann, Stefan Knapp
Published 2023-08-01

PB1813: REGULATORY MECHANISMS AND THERAPEUTIC POTENTIAL OF THE DLK1-DIO3 LOCUS IN PEDIATRIC ACUTE MEGAKARYOBLASTIC LEUKEMIA

by Lonneke Verboon, Hasan Issa, Dirk Heckl, Jan-Henning Klusmann
Published 2023-08-01

P419: HARNESSING MIRNA-193B-3P MIMIC AS A POTENT THERAPEUTIC OPTION IN ACUTE MYELOID LEUKEMIA

by Hasan Issa, Raj Bhayadia, Robert Winkler, Dirk Heckl, Jan-Henning Klusmann
Published 2023-08-01

Segregated by Wealth, Health, and Development: An Analysis of Pre-School Child Health in a Medium-Sized German City

by Karoline Wagner, Andreas Wienke, Christine Gröger, Jan-Henning Klusmann, Amand Führer
Published 2023-05-01

Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML

by Franziska Schmidt, Miriam Erlacher, Charlotte Niemeyer, Dirk Reinhardt, Jan-Henning Klusmann
Published 2022-11-01

Flow Cytometric Analysis of Autophagic Activity with Cyto-ID Staining in Primary Cells

by Metodi Stankov, Diana Panayotova-Dimitrova, Martin Leverkus, Jan-Henning Klusmann, Georg Behrens
Published 2014-04-01

DNMT3A mutations are rare in childhood acute myeloid leukemia

by Felicitas Thol, Michael Heuser, Frederik Damm, Jan-Henning Klusmann, Katarina Reinhardt, Dirk Reinhardt
Published 2011-08-01

RNA-Binding Proteins in Acute Leukemias

by Konstantin Schuschel, Matthias Helwig, Stefan Hüttelmaier, Dirk Heckl, Jan-Henning Klusmann, Jessica I Hoell
Published 2020-05-01

P467: LONG NON-CODING RNA SNHG29 IS A NOVEL MYELOID LEUKEMIA DEPENDENCY

by Robert Winkler, Dirk Heckl, Michelle Ng, Reinier Boon, Hasan Issa, Raj Bhayadia, Jan-Henning Klusmann
Published 2023-08-01

PB1825: IDENTIFYING GENE TARGETS FOR DRUG REPURPOSING TO COUNTER MYELOID LEUKEMIA IN CHILDREN WITH DOWN-SYNDROME (ML-DS)

by Anna-Lena Schmell, Kristof Meier, Oriol Alejo-Valle, Dirk Heckel, Raj Bhayadia, Jan-Henning Klusmann
Published 2023-08-01

GATA1s exerts developmental stage-specific effects in human hematopoiesis

by Sofia Gialesaki, Anna Katharina Mahnken, Lena Schmid, Maurice Labuhn, Raj Bhayadia, Dirk Heckl, Jan-Henning Klusmann
Published 2018-08-01

The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study

by Jan-Henning Klusmann, Dirk Reinhardt, Martin Zimmermann, Bernhard Kremens, Josef Vormoor, Michael Dworzak, Ursula Creutzig, Thomas Klingebiel
Published 2012-01-01

Autolysosomal activation combined with lysosomal destabilization efficiently targets myeloid leukemia cells for cell death

by Harshit Shah, Metodi Stankov, Diana Panayotova-Dimitrova, Amir Yazdi, Ramachandramouli Budida, Jan-Henning Klusmann, Georg M. N. Behrens
Published 2023-02-01

CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells in vivo

by Jana Reimer, Sabine Knöß, Maurice Labuhn, Emmanuelle M. Charpentier, Gudrun Göhring, Brigitte Schlegelberger, Jan-Henning Klusmann, Dirk Heckl
Published 2017-09-01

Low frequency of type-I and type-II aberrations in myeloid leukemia of Down syndrome, underscoring the unique entity of this disease

by Marjolein Blink, Marry M. van den Heuvel-Eibrink, Valerie de Haas, Jan-Henning Klusmann, Henrik Hasle, C. Michel Zwaan
Published 2012-04-01

ErbB2 (HER2)-CAR-NK-92 cells for enhanced immunotherapy of metastatic fusion-driven alveolar rhabdomyosarcoma

by Catrin Heim, Laura M. Moser, Laura M. Moser, Laura M. Moser, Laura M. Moser, Herman Kreyenberg, Halvard B. Bonig, Halvard B. Bonig, Torsten Tonn, Torsten Tonn, Winfried S. Wels, Winfried S. Wels, Winfried S. Wels, Elise Gradhand, Elise Gradhand, Evelyn Ullrich, Evelyn Ullrich, Evelyn Ullrich, Evelyn Ullrich, Michael T. Meister, Michael T. Meister, Marian Groot Koerkamp, Marian Groot Koerkamp, Frank C. P. Holstege, Frank C. P. Holstege, Jarno Drost, Jarno Drost, Jan-Henning Klusmann, Jan-Henning Klusmann, Jan-Henning Klusmann, Jan-Henning Klusmann, Peter Bader, Peter Bader, Michael Merker, Michael Merker, Eva Rettinger, Eva Rettinger, Eva Rettinger, Eva Rettinger
Published 2023-08-01